Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
7m agoProWood TrueFrame Joist Now Available Across Northeast, South Atlantic
7m agoParker to Acquire CIRCOR’s Commercial and Defense Aerospace Business
7m agoToll Brothers Announces Cedar Terrace Community Now Open in Chantilly, Virginia
7m agoWhen Blood Compatibility Becomes a Pregnancy Risk
7m agoTony and Grammy Award-Winning Leslie Odom, Jr. to Headline Blackbaud's bbcon 2026 Social Impact Tech Conference
Atyr Pharma, Inc. logo

Atyr Pharma, Inc.

About

0.54USD+0.01 +1.42%
Closed • Updated at 13:55 GMT+00:00
Market Cap$52.77M
Volume135.6K
Beta1.06
RSI39.91
Gross Margin-723.16%
Health TechnologyPharmaceuticals: Major

Atyr Pharma, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

May 15 2026
aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update
May 13 2026
aTyr Pharma to Participate in Upcoming Investor Conferences
May 11 2026
aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting
Mar 5 2026
aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update
Feb 3 2026
aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis

Community Chat

Ask AI

6ix6ixAIEvents